TABLE 1.
Drug Pharmacologya | Doses | Route | Strain/Species | Sex | ICSS Procedureb | Drug Effectc | Dependent Measure | Reference | ||
---|---|---|---|---|---|---|---|---|---|---|
Drug Name | Selectivity | Structure | Parameter | |||||||
mg/kg | ||||||||||
Amphetamine | DA/NE>5HT | 0.1–2.0 | i.p. | Sprague-Dawley rat | Male | Free operant | Facilitation | ↑rate | Carey et al., 1974 | |
Amphetamine | DA/NE>5HT | 0.25–2.0 | i.p. | Fischer rat | Male | Discrete trial | Amplitude | Facilitation | ↓CIT | Esposito et al., 1980 |
Amphetamine | DA/NE>5HT | 0.032–1.0 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Facilitation | ↓θ0 ↑rate | Bauer et al., 2013b |
Amphetamine | DA/NE>5HT | 1.0–4.0 | i.p. | C57Bl6/J mouse | Male | Hybrid | Frequency | Facilitation | ↓M50 | Elmer et al., 2010 |
Amphetamine | DA/NE>5HT | 1.0–4.0 | i.p. | DBA/2J mouse | Male | Hybrid | Frequency | Facilitation | ↓M50 | Elmer et al., 2010 |
(+)-Phenmetrazine | DA/NE>5HT | 0.32–10 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Facilitation | ↓θ0 ↑rate | Bauer et al., 2013b |
m-Fluroamphetamine | DA/NE>5HT | 1.0–3.2 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Facilitation | ↓θ0 ↑rate | Bauer et al., 2013b |
(+)-Methamphetamine | DA/NE>5HT | 0.032–1.0 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Facilitation | ↓θ0 ↑rate | Bauer et al., 2013b |
(±)Methcathinone | DA/NE>5HT | 0.1–1.0 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Facilitation | ↑rate | Bonano et al., 2014 |
PAL-314 | DA/NE>5HT | 0.32–10 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Mixed | ↓θ0 ↑↓rate | Bauer et al., 2013b |
PAL-313 | DA/NE/5HT | 0.32–3.2 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Mixed | ↓θ0 ↑↓rate | Bauer et al., 2013b |
(+)MDMA | DA/NE/5HT | 0.1–3.2 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Mixed | ↓θ0 ↑↓rate | Bauer et al., 2013b |
PAL-287 | DA/NE/5HT | 0.32–10 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Mixed | ↓θ0 ↑↓rate | Bauer et al., 2013b |
(−)MDMA | DA<NE/5HT | 0.32–3.2 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Mixed | ↑↓rate | Bauer et al., 2013b |
(±)Methylone | DA/NE/5HT | 1.0–10 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Mixed | ↑↓rate | Bonano et al., 2014 |
(±)Mephedrone | DA/NE/5HT | 1.0–10 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Mixed | ↑↓rate | Bonano et al., 2014 |
(±)Mephedrone | DA/NE/5HT | 1.0–10 | i.p. | C57Bl6/J mouse | Male | Hybrid | Frequency | Mixed | ↓θ0 ↓EF50 | Robinson et al., 2012 |
PAL-544 | DA/NE/5HT | 0.32–3.2 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Mixed | ↑↓rate | Banks et al., 2014 |
PAL-571 | DA/NE/5HT | 0.32–3.2 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Mixed | ↑↓rate | Banks et al., 2014 |
PAL-569 | DA<NE/5HT | 0.32–3.2 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Depression | ↓rate | Banks et al., 2014 |
PAL-542 | DA/5HT>NE | 0.32–3.2 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Depression | ↓rate | Banks et al., 2014 |
Fenfluramine | DA<5HT/NE | 0.32–3.2 | i.p. | Sprague-Dawley rat | Male | Hybrid | Frequency | Depression | ↓rate | Bauer et al., 2013b |
Fenfluramine | DA<5HT/NE | 20 | i.p. | Sprague-Dawley rat | Male | Free operant | Depression | ↓rate | Olds, 1995 |
Rate, response rate; CIT, current-intensity threshold; θ0: theta-0 threshold; M50 or EF50, frequency maintaining 50% maximum rate.
Selectivity for monoamine release.
First colunn indicates structure of experimental session (see text for details). Second column indicates stimulation parameter under manipulation across trials.
Most prominent drug effect on ICSS.